financetom
Business
financetom
/
Business
/
UK patients unlikely to get access to Eisai-Biogen's Alzheimer's drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK patients unlikely to get access to Eisai-Biogen's Alzheimer's drug
Aug 23, 2024 12:30 AM

Aug 22 (Reuters) - Alzheimer's patients in Britain's

state-run health service is unlikely to get access to Eisai ( ESALF )

and Biogen's new Leqembi drug, after it was

approved by the country's regulator but deemed too expensive for

wide use on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Warner Bros. Acquisition Must Undergo 'Robust' Antitrust Review, California AG Says
Warner Bros. Acquisition Must Undergo 'Robust' Antitrust Review, California AG Says
Mar 11, 2026
01:04 PM EST, 02/20/2026 (MT Newswires) -- Warner Bros. Discovery's ( WBD ) proposed acquisition by either Netflix ( NFLX ) or Paramount Skydance ( PSKY ) must undergo a robust antitrust review, California Attorney General Rob Bonta said in a Friday statement. The proposed Warner Brothers transactions must receive a full and robust review, and California is taking a...
KKR explores $1.5 billion sale of BMC Helix, sources say
KKR explores $1.5 billion sale of BMC Helix, sources say
Mar 11, 2026
NEW YORK, Feb 20 (Reuters) - Private equity firm KKR is exploring a sale of its information services provider BMC Helix, which could fetch as much as $1.5 billion, according to people ​familiar with the matter.  Helix, which is being ‌advised by investment bankers at Jefferies, has already received initial bids from other private equity ⁠firms and corporate buyers, the...
Wedbush
Wedbush "Encouraged" by Study on Fennec's Pedmark's Impact on Adults Treated With Cisplatin
Mar 11, 2026
01:11 PM EST, 02/20/2026 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) presented real world data showing early signals of hearing preservation in adults treated with platinum-based chemotherapy for head and neck cancer, notes Wedbush. In a note, analyst David Nierengarten, who has an outperform rating and US$13.00 price target on the stock, said the majority of high-risk patients, including...
Hungary to release 1.8 million barrels of crude oil from strategic reserves
Hungary to release 1.8 million barrels of crude oil from strategic reserves
Mar 11, 2026
* Hungary and Slovakia have been trying to secure supplies since attack on Druzhba pipeline * Pipeline operator JANAF questions Hungary's need to tap reserves * Hungary's MOL oil firm says JANAF must allow transit of Russian seaborne oil (Updates with statement from Croatia's JANAF pipeline operator in paragraphs 2-4) BUDAPEST, Feb 20 (Reuters) - ​Hungary's government will release about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved